Best Healthcare Companies in Provence Alpes Cote d Azur, France
The 47 best Healthcare companies in Provence Alpes Cote d Azur, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Provepharm Life Solutions.
Ranked: Best Healthcare companies in Provence Alpes Cote d Azur
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Provepharm Life Solutions Pharmaceutical company dedicated towards the development and valorization of APIs and drug Products | $146M | 59 mo ago | Late Stage | Michel Feraud CEO | 1998 | Apple iCloud MailMicrosoft 365Ruby+16 | 100 patents Patents concentrated in chemistry & materials | — |
| 2 | Almaviva Sante Chains providing medical care, surgical services, and specialized treatment options | $48M | 153 mo ago | Acquired | Bruno Marie CEO | 2007 | PHPamChartsZURB Foundation+13 | — | 1 job opening · 2 expansions |
| 3 | Innate Pharma Developer of antibody based therapeutics to treat cancer 76Fin. health top 17%Patents top 21%Funding top 28%Talent top 28% All 11 signals ▾Fin. healthtop 17% Patentstop 21% Fundingtop 28% Talenttop 28% Innovationtop 32% Markettop 34% Moattop 40% Globaltop 48% Techbottom 49% Growthbottom 47% Newsbottom 47% Fin. health: Revenue ~$62.3M (FY2016) · Net margin 23.3% Patents: 1,175 patents matched (strict assignee match) · 266 filings since 2022 vs 455 in 2017-21 rank vs industry peers · Fliar Intelligence Index 76/100 | $43M | 15 mo ago | Public | Marc Bonneville Co-Founder | 1999 | Apple iCloud MailMicrosoft 365Q4+14 | 1,170 patents Engineered immune cell therapies and antibody engineering for cancer immunotherapy | — |
| 4 | Horus Pharma Developer of ophthalmology pharmaceutical products | $25M | 53 mo ago | Series B | Martine Claret Co-Founder & President | 2003 | PrestaShopPleskApple iCloud Mail+13 | 117 patents Topical hyaluronic acid emulsions and innovative dispensing/packaging devices for dermatology. | 1 award |
| 5 | Biotech Dental Manufacturer of dental implants and other equipment | $24M | 66 mo ago | Acquired | Philippe Veran Co-founder & President | 1987 | Cart FunctionalityWordPressTypeScript+31 | 74 patents Dental implant prosthetics, surgical guides, and bone regeneration technologies. | 1 award |
| 6 | INELDEA Contract manufacturing of dietary and cosmetic supplements | $12M | 104 mo ago | Late Stage | Nicolas Cappelaere Founder & CEO | 2003 | WordPressMySQLPHP+21 | — | 1 launch · 1 expansion |
| 7 | Rofim R&D company focused on manufacturing of diagnostic products for multiple therapeutic areas | $6M | 10 mo ago | Series B | Virgile Omnes Co-Founder | 2018 | MUIReactReact Router+11 | — | 1 partnership |
| 8 | Phytocann Manufacturer of cannabis focused products | $5M | 47 mo ago | Series A | — | 2016 | — | — | — |
| 9 | mtBiolabs Laboratory focused on in-vitro mitochondrial testing & research | $2M | 170 mo ago | Series A | Nathalie Compagnone Co-Founder & CEO | 2007 | — | — | — |
| 10 | Eurobiomed Association focused on developing and marketing of innovative healthcare products | $119K | 94 mo ago | Funding Raised | Emilie Royere Managing Director | 2009 | WordPressPleskMySQL+17 | — | — |
| 11 | 3D Medlab Provider of engineering, design and production of medical devices in additive manufacturing | $78K | 73 mo ago | Funding Raised | Gael Volpi Founder & President | 2017 | — | 5 patents 4D additive manufacturing of hydrogel-based medical devices and implants | — |
| 12 | Neuro-Sys Preclinical CRO specializing in neurodegenerative diseases | $24K | 113 mo ago | Funding Raised | Yann Jaudouin Co-Founder & CEO | 2013 | WixSentryBootstrap+10 | — | — |
| 13 | Virbac Provider of animal health products, services, and diagnostic solutions | — | 26 mo ago | Public | Paul Martingell CEO | 1968 | — | 450 patents Veterinary drug delivery, hormone release, and parasite control for companion and farm animals | — |
Top 12 Healthcare companies in Provence Alpes Cote d Azur
#1
Public · Marseille, Provence Alpes Cote d Azur · founded 1999 · 191 employees$43.5Mraised▾
Developer of antibody-based therapeutics to treat cancer. The company's portfolio include lacutamab, developed in an advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, monalizumab in non-small cell lung cancer, as well as ANKET multi-specific NK cell engagers to address multiple tumor types.
- Apr 2025Post IPO$17.1M
- Jun 2018Grant (prize money)$306.7K
- Jan 2017Post IPO$15M
- Jun 2014Post IPO$68.1M
#2
Series B · Marseille, Provence Alpes Cote d Azur · founded 2018 · 22 employees$5.8Mraised▾
Provider of a telemedicine platform designed for sharing clinical and patient-related data between doctors, clinics, and patients. The company's platform provides access to clinical description data and medical imaging in real-time, lets users connect to doctors and request health-related information, and features secure exchange and file-sharing tools, enabling doctors to organize and communicate health data and offer medical consultation to patients, anytime, and from anyplace.
- Sep 2025Series B$11.7M
- Oct 2021Series A$5.8M
#3
Late Stage · Marseille, Provence Alpes Cote d Azur · founded 1998 · 125 employees$145.9Mraised▾
Provepharm is a specialty pharma company, offering specialty products, preclinical services, API production & FDF for the clinical trial. The company products include methylene blue compound, methylthioninium chloride solution, methylene blue solution for injection, and methylrnr blue sterile solution.
- Sep 2021PE$142.3M
- May 2019Conventional Debt$47.6M
- Mar 2018PE—
- Dec 2011PE$3.6M
#4
Series B · St Laurent du Var, Provence Alpes Cote d Azur · founded 2003 · 220 employees$25.2Mraised▾
Developer of ophthalmology pharmaceutical products
- Mar 2022Series B$25.2M
- Mar 2015Grant (prize money)$54.3K
- Oct 2014Grant (prize money)$63K
#5
Acquired · Salon de Provence, Provence Alpes Cote d Azur · founded 1987 · 800 employees$24.2Mraised▾
Manufacturer of dental implants and other equipment
- Jan 2021Series B$24.2M
- 2009PE—
#6
Acquired · Marseille, Provence Alpes Cote d Azur · founded 2007 · 4700 employees$48.1Mraised▾
Chains providing medical care, surgical services, and specialized treatment options. They offer a range of healthcare services, including medical imaging. The organization focuses on delivering patient care through its network of facilities. It provides various medical specialties and personalized services.
- Nov 2013PE$48.1M
#7
Series A · Arles, Provence Alpes Cote d Azur · founded 2016 · 17 employees$5.1Mraised▾
Manufacturer of cannabis focused products
- Aug 2022Series A$5.1M
#8
Late Stage · Carros, Provence Alpes Cote d Azur · founded 2003 · 113 employees$11.8Mraised▾
Ineldea Laboratories is engaged in contract manufacturing and marketing of dietary and cosmetic supplements. The company has developed products for STC Nutrition, Pediakind, Olioseptil, Ineldea Natural Health, Vitamin'22, Nutriexpert- Specialties, Efficolor, Effiderm, Medicafarm.
- Dec 2017PE$11.8M
#9
Series A · Auriol, Provence Alpes Cote d Azur · founded 2007$1.6Mraised▾
Laboratory focused on in-vitro mitochondrial testing & research
- 2012Series A$1M
- 2009Seed$557.8K
#10
Funding Raised · Marignane, Provence Alpes Cote d Azur · founded 2017 · 11 employees$78.1Kraised▾
Provider of engineering, design and production of medical devices in additive manufacturing
- Jul 2020Grant (prize money)$78.1K
#11
Funding Raised · Marseille, Provence Alpes Cote d Azur · founded 2009$118.9Kraised▾
Association focused on developing and marketing of innovative healthcare products
- Oct 2018Grant (prize money)$118.9K
#12
Funding Raised · Gardanne, Provence Alpes Cote d Azur · founded 2013$23.6Kraised▾
Neuro-Sys is a preclinical CRO specializing in neurodegenerative diseases. The company offers primary cultures for the study of effects of drugs for a wide range of CNS diseases including Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, peripheral neuropathies, and ALS. They also offer blood-brain-barrier models to study the penetration of drugs. The company also identifies and develops new compounds from selected medicinal plants which have a proven efficacy on neurodegenerative diseases. The company also offers pharmacological and clinical services for nutraceutical development.
- Mar 2017Grant (prize money)$23.6K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.